CVS Health Corporation
- Jurisdiction
United States - LEI
549300EJG376EN5NQE29 - ISIN
US1266501006 (CVS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€118.66 76.9% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
CVS Health Corporation provides health services in the United States. Read full profile
Fundamentals
- Net revenue
€329.79B - Gross margin
13.8% - EBIT
€7.64B - EBIT margin
2.3% - Net income
€3.86B - Net margin
1.2%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.67 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
74.6%
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Finucane Anne A. | N/A |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Val Hoyle | September 12, 2025 | $1.00K–$15.00K |
| Adam Smith | August 8, 2025 | $1.00K–$15.00K |
| Jefferson Shreve | June 22, 2025 | $15.00K–$50.00K |
| Robert Bresnahan | May 31, 2025 | $1.00K–$15.00K |
| Julie Johnson | May 14, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Samantha McLemore |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Buy |
| Peter Brown |
|
|
|
Sell |